PHC-12-2015-1
PHC-12-2015-1
87 projects · €4,350,000 total EU contribution (project-level) · 88 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€4,350,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (12)
- Germany (11)
- Spain (11)
- Italy (11)
- SE (8)
- France (6)
- IL (6)
- DK (4)
- AT (3)
- HU (3)
- IE (2)
- Netherlands (2)
- BE (1)
- BG (1)
- EE (1)
- FI (1)
- IS (1)
- NO (1)
- PT (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AETHRA TELECOMMUNICATIONS1 projects · IT
- ACONET1 projects · IT
- ADAPTIX1 projects · UK
- BIFARMA1 projects · HU
- ALAM MEDICAL1 projects · FR
- ANANDA PHARMA1 projects · DE
- ANAXSYS TECHNOLOGY LTD1 projects · UK
- ANGIOTARGET BV1 projects · NL
- AROCELL AB1 projects · SE
- ATTOMARKER LIMITED1 projects · UK
- Atturos1 projects · IE
- AVERBIS GMBH1 projects · DE
Projects
Page 8 of 9
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Spectra- A novel diagnostic device to improve retinal imaging Spectra · 684584 | H2020 | €50,000 | €71,429 | Details |
“Diagnosis of Ischemic Heart Disease by means of innovative and highly accurate high frequency QRS electrocardiogram analysis” HYPERQTOTAL · 709835 | H2020 | €50,000 | €71,429 | Details |
Safe and discrete gastrostomy tube for enteral feeding improving the delivery of nutrition and patient care. GFeed · 710834 | H2020 | €50,000 | €71,429 | Details |
A simple blood test to monitor disease progression in patients undergoing cancer therapy ONCOCHECK · 696293 | H2020 | €50,000 | €71,429 | Details |
Rapid heat inactivation of pathogens to enable biomarker research RIPEB · 683475 | H2020 | €50,000 | €71,429 | Details |
Immune Monitoring for RIsk STratification in Solid Organ Transplant Recipients ImMoRiSt · 710079 | H2020 | €50,000 | €71,429 | Details |
Diagnosis and Exclusion of Drug-Induced Liver Injury by using Patient Blood Samples (DILITEST) DILITEST · 711620 | H2020 | €50,000 | €71,429 | Details |
NON INVASIVE DIAGNOSTIC TEST SERVICE FOR “NON ALCOHOLIC FATTY LIVER DISEASE” MANAGEMENT DeMILI · 717419 | H2020 | €50,000 | €71,429 | Details |
TOPO-TB TOPO-TB · 698260 | H2020 | €50,000 | €71,429 | Details |
Heart monitoring and early assistance in high risk crisis without patient intervention (COPCAR) COPCAR · 717805 | H2020 | €50,000 | €71,429 | Details |